Cargando…
Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema
Macular edema is one of the leading causes of vision loss among patients with retinal vein occlusion, diabetic retinopathy, and posterior chamber inflammatory disease. However, the treatment of macular edema is considerably limited by the difficulty in delivering effective doses of therapeutic agent...
Autores principales: | Herrero-Vanrell, Rocío, Cardillo, Jose Augusto, Kuppermann, Baruch D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045060/ https://www.ncbi.nlm.nih.gov/pubmed/21383939 http://dx.doi.org/10.2147/OPTH.S15783 |
Ejemplares similares
-
Intralenticular Sustained-Release Dexamethasone Implant: Is It Still Effective on Macular Edema?
por: Sekeroglu, Mehmet Ali, et al.
Publicado: (2016) -
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study
por: Augustin, Albert J., et al.
Publicado: (2015) -
Intravitreal sustained-release dexamethasone implant for the treatment of persistent cystoid macular edema in ocular syphilis
por: Majumder, Parthopratim Dutta, et al.
Publicado: (2019) -
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015) -
Widening use of dexamethasone implant for the treatment of macular edema
por: Bonfiglio, Vincenza, et al.
Publicado: (2017)